Author
Listed:
- Vrutant V. Shah
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Aundrietta D. Duncan
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of Texas
Salarius Pharmaceuticals)
- Shiming Jiang
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Sabrina A. Stratton
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Kendra L. Allton
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Clinton Yam
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Abhinav Jain
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of Texas)
- Patrick M. Krause
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Yue Lu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Shirong Cai
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Yizheng Tu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Xinhui Zhou
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Xiaomei Zhang
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Yan Jiang
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Christopher L. Carroll
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Zhijun Kang
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Bin Liu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Jianjun Shen
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Mihai Gagea
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Sebastian M. Manu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Lei Huo
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Michael Gilcrease
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Reid T. Powell
(Texas A&M College of Medicine)
- Lei Guo
(Texas A&M College of Medicine)
- Clifford Stephan
(Texas A&M College of Medicine)
- Peter J. Davies
(Texas A&M College of Medicine)
- Jan Parker-Thornburg
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Guillermina Lozano
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of Texas)
- Richard R. Behringer
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of Texas)
- Helen Piwnica-Worms
(The University of Texas MD Anderson Cancer Center
University of Texas
The University of Texas MD Anderson Cancer Center)
- Jeffrey T. Chang
(University of Texas
University of Texas Health Sciences Center at Houston)
- Stacy L. Moulder
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Michelle Craig Barton
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of Texas
Center Knight Cancer Institute Oregon Health & Science University)
Abstract
Conditional overexpression of histone reader Tripartite motif containing protein 24 (TRIM24) in mouse mammary epithelia (Trim24COE) drives spontaneous development of mammary carcinosarcoma tumors, lacking ER, PR and HER2. Human carcinosarcomas or metaplastic breast cancers (MpBC) are a rare, chemorefractory subclass of triple-negative breast cancers (TNBC). Comparison of Trim24COE metaplastic carcinosarcoma morphology, TRIM24 protein levels and a derived Trim24COE gene signature reveals strong correlation with human MpBC tumors and MpBC patient-derived xenograft (PDX) models. Global and single-cell tumor profiling reveal Met as a direct oncogenic target of TRIM24, leading to aberrant PI3K/mTOR activation. Here, we find that pharmacological inhibition of these pathways in primary Trim24COE tumor cells and TRIM24-PROTAC treatment of MpBC TNBC PDX tumorspheres decreased cellular viability, suggesting potential in therapeutically targeting TRIM24 and its regulated pathways in TRIM24-expressing TNBC.
Suggested Citation
Vrutant V. Shah & Aundrietta D. Duncan & Shiming Jiang & Sabrina A. Stratton & Kendra L. Allton & Clinton Yam & Abhinav Jain & Patrick M. Krause & Yue Lu & Shirong Cai & Yizheng Tu & Xinhui Zhou & Xia, 2021.
"Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer,"
Nature Communications, Nature, vol. 12(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25650-z
DOI: 10.1038/s41467-021-25650-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25650-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.